Automated PET-only quantification of amyloid deposition with adaptive template and empirically pre-defined ROI

G Akamatsu1, Y Ikari, A Ohnishi

  • 1Division of Molecular Imaging, Institute of Biomedical Research and Innovation 2-2, Minatojima-Minamimachi, Chuo-ku, Kobe 650-0047, Japan.

Insights

This study demonstrates a novel PET-only method for quantifying amyloid deposition in Alzheimer's disease (AD). This approach accurately assesses amyloid levels without requiring MRI, simplifying diagnosis and monitoring of AD therapy.

Area of Science:

  • Neuroimaging
  • Radiochemistry
  • Medical Diagnostics

Background:

  • Amyloid Positron Emission Tomography (PET) is crucial for Alzheimer's disease (AD) diagnosis and therapy monitoring.
  • Standard quantification often relies on MRI for spatial normalization, which is not always available clinically.
  • Developing MRI-independent quantification methods is essential for broader clinical application.

Purpose of the Study:

  • To assess the feasibility of a PET-only amyloid quantification method.
  • To develop an adaptive template and empirically generated region-of-interest (ROI) for quantification without MRI.
  • To compare PET-only quantification results with standard MRI-based methods.

Main Methods:

  • Utilized (11)C-PiB PET data from 68 subjects.
  • Developed an adaptive template and an Empirical PiB-prone ROI (EPP-ROI) using typical positive and negative scans.
  • Spatially normalized PET images to a standard MNI atlas and calculated Standardized Uptake Value Ratio (SUVR).
  • Compared SUVRs from PET-only and MRI-based methods and evaluated classification accuracy.

Main Results:

  • PET-only quantification using EPP-ROI yielded SUVR values nearly identical to MRI-based methods.
  • A significant correlation was observed between SUVRs from AAL-ROI and EPP-ROI.
  • All (11)C-PiB scans were accurately categorized as positive or negative using a cutoff SUVR of 1.7.

Conclusions:

  • The developed PET-only amyloid quantification method is accurate, robust, and simple.
  • This approach eliminates the need for MRI, enhancing accessibility for AD diagnosis and research.
  • The method provides reliable quantification and classification of amyloid deposition.

Related Concept Videos